- Discharge prevention to wastewater for about 10 m3 per day (3650 m3/year) of wastewater contaminated with traces of antibiotics that may contribute to the development of antimicrobial resistance.
- 1,606 kg of APIs will be converted to nontoxic compounds before being discharged in the wastewater sewage system per year.
- Elimination of environmental impacts occurring due to poor controlled discharge of APIs in the wastewater sewage system.
- Minimize the environmental footprint of the system using 100% renewable energy sources.
- Policy recommendations in the EU, due to relevant results of the project, for treatment of wastewater effluent containing traces of APIs (Active Pharmaceutical Ingredients).
- Further development of a new, innovative method for the detoxification of APIs and upscaling of the method from the lab/pilot scale to the industrial scale for the treatment of pharmaceutical industry wastewater.
- Demonstrate a novel technology for the treatment of pharmaceutical wastewater, which will fully exploit (operate with) renewable energy (solar).
- Use of an economically viable, cost-effective method for the detoxification of pharmaceutical substances in a pharmaceutical facility wastewater.
- Communication and promotion of public awareness at local and regional level, authorities, universities and pharmaceutical manufacturing industries.